196
12
9
Citations
Documents
h-index
Featured Publications
Global Antimicrobial Resistance and Use Surveillance System on the African Continent: Early Implementation (2017–2019)
– African Journal of Laboratory Medicine, 2022
Dr. Laetitia Gahimbare is a medical doctor specialized in Clinical Pathology and Epidemiology with over 20 years of experience in antimicrobial resistance (AMR) surveillance, laboratory systems strengthening, and public health preparedness across Africa. She currently serves as Technical Officer for AMR Surveillance, Evidence and Laboratory Strengthening at the WHO Regional Office for Africa, providing strategic and hands-on leadership to 47 Member States. A recognized expert in GLASS implementation, AMR/AMU surveillance, laboratory quality management, and One Health approaches, she has extensive experience translating surveillance data into policy-relevant evidence. Her work spans post-outbreak recovery, AMR simulation exercises, capacity building, and multisectoral coordination, with numerous contributions to regional reports, peer-reviewed publications, and policy briefs.
Citations
Documents
h-index
Ortenau Klinikum Offenburg-Kehl, Germany.
PD Dr. med. Viviane Zotzmann is a Senior Consultant for Intensive Care Medicine at Ortenau Klinikum, specializing in internal medicine and cardiology with additional expertise in emergency and intensive care medicine. She has trained in both municipal hospitals and the University Hospital of Freiburg. Dr. Zotzmann is currently responsible for two intensive care units in Offenburg and Lahr. Her research focuses on ECMO therapy, with particular interest in survival predictors, quality of life, and functional outcomes post-therapy. She is an active member of professional societies such as DGK, DEGUM, DIVI, and DGIM.
Dr. Viviane Zotzmann holds a Doctor of Medicine (Dr. med.) degree from the University of Tübingen (2005). She is a board-certified specialist in Internal Medicine (2013), Cardiology (2017), and Intensive Care Medicine (2018), with further certification in Cardiovascular Intensive and Emergency Medicine (2022). In addition, she is an Advanced Life Support & Pediatric Life Support Provider (2023). Dr. Zotzmann has also completed additional training in Sonography, Emergency Medicine, and Radiation Protection.
Dr. Viviane Zotzmann is a highly experienced medical professional specializing in intensive care, cardiology, and emergency medicine. She currently serves as the Head of Intensive Care Medicine at Ortenau Klinikum (2025 – Present). Previously, she held the position of Senior Consultant at Ortenau Klinikum (2023 – 2025), overseeing Cardiology, Pneumology, Angiology, Geriatrics, Intensive Care, and Thoracic Surgery.
From 2020 to 2023, Dr. Zotzmann was the Lead Physician of Medical Intensive Care Units at University Hospital Freiburg, following her role as a Specialist Physician at the same institution (2016 – 2020). Before that, she served as Senior Physician in Internal Medicine/Cardiology at Zollernalbklinikum (2014 – 2015).
Her medical journey began with specialist training in Internal Medicine & Cardiology at KKH Sigmaringen (2010 – 2014), solidifying her expertise in critical and cardiovascular care.
Extracorporeal Membrane Oxygenation (ECMO) therapy
Predictors of survival in VV-ECMO and VA-ECMO patients
Quality of life and mental health in post-ECMO patients
Pulmonary embolism diagnosis in ICU patients
Advanced intensive care monitoring and life-support techniques
Recognized contributor to ECMO research
Published in high-impact journals such as Intensive Care Medicine and Membranes (Basel)
Cited over 1,044 times with an h-index of 18
Quality of Life and Mental Health in COVID-ARDS Survivors After V-V ECMO Support: Results from the Freiburg ECMO Outcome Study (FEOS)
Journal of Clinical Medicine, 2025-03-24
DOI: 10.3390/jcm14072206
Contributors: Dawid L. Staudacher, Meret Felder, Markus Jäckel, Felix A. Rottmann, Alexander Supady, Xavier Bemtgen, Philipp Diehl, Tobias Wengenmayer, Viviane Zotzmann
Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients
Journal of Thrombosis and Thrombolysis, 2021-07-03
DOI: 10.1007/s11239-020-02323-0
Contributors: Viviane Zotzmann, Corinna N. Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher
Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients (Preprint)
2020-09-08
DOI: 10.21203/rs.3.rs-70085/v1
Contributors: Viviane Zotzmann, Corinna Nadine Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher
Venoarterial Extracorporeal Membrane Oxygenation Decannulation Using the Novel Manta Vascular Closure Device
European Heart Journal: Acute Cardiovascular Care, 2020-05-04
DOI: 10.1177/2048872620918707
Author: V. Zotzmann
Are Subpleural Consolidations Indicators for Segmental Pulmonary Embolism in COVID-19?
Intensive Care Medicine, 2020-04-23
DOI: 10.1007/s00134-020-06044-z
Author: V. Zotzmann
Federal Ministry of Health, Nigeria.
Dr. Solomon Monday Jacob (JSM) is a seasoned Medical Parasitologist and a Chief Medical Laboratory Scientist at the Federal Ministry of Health, Nigeria. He serves as the Technical Lead for the National Schistosomiasis and Soil-Transmitted Helminthiasis Control Programme, playing a pivotal role in expanding Neglected Tropical Diseases (NTDs) control in Nigeria. With vast experience in malaria, onchocerciasis, lymphatic filariasis, and NTD research, he has contributed significantly to disease prevention strategies. He has published numerous research papers and collaborates with global organizations on healthcare innovations.
Dr. Solomon Jacob holds a PhD in Medical Laboratory Science with a specialization in Medical Parasitology. His academic journey has equipped him with in-depth knowledge of infectious diseases, epidemiology, and diagnostic techniques. In addition to his doctorate, he has undergone extensive training in Neglected Tropical Diseases (NTD) control programs, focusing on strategies for disease surveillance, prevention, and treatment. His expertise in disease epidemiology has enabled him to contribute significantly to public health initiatives, research projects, and policy development aimed at reducing the burden of NTDs in Nigeria and beyond.
Dr. Solomon Jacob is a dedicated Program Officer for Neglected Tropical Diseases (NTDs) at the Federal Ministry of Health, Nigeria, where he plays a crucial role in formulating and implementing national disease control strategies. As a Chief Medical Laboratory Scientist, he leads technical initiatives for the Schistosomiasis & Soil-Transmitted Helminthiasis Control Programme, focusing on innovative approaches to diagnosis, treatment, and eradication efforts.
Beyond his government role, Dr. Jacob serves as a Researcher and Consultant, contributing to significant projects on Malaria, Onchocerciasis, Lymphatic Filariasis, and other NTDs. His work involves operational research, policy advisory, and capacity building to strengthen disease surveillance and control measures. Additionally, he is an Editorial Board Member for renowned scientific journals such as PLoS NTD and Elsevier, furthering his impact in global health research.
Neglected Tropical Diseases (NTDs) 🦠
Schistosomiasis & Soil-Transmitted Helminthiasis 🏥
Malaria & Vector-Borne Diseases 🦟
Onchocerciasis & Lymphatic Filariasis 🏨
Public Health & Disease Control Strategies
Recognized for strategic contributions to NTD control in Nigeria
Lead researcher in multiple operational health projects
Editorial Appointments with PLoS NTD, Elsevier
Schistosomiasis and Soil Transmitted Helminthiasis Among School-Age Children: Impact of 3–5 Annual Rounds of Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-03-23 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed10040085
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Akande Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.
Impact of Preventive Chemotherapy on the Prevalence of Schistosomiasis and Soil-Transmitted Helminthiasis Among School-Age Children After 3–5 Effective Rounds of Annual Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-01-27 | Preprint
🔗 DOI: 10.20944/preprints202501.1916.v1
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.
Impact of Praziquantel Mass Drug Administration after Several Rounds on Schistosomiasis Among School-Aged Children in Abuja, Nigeria
🗓 2025-01-22 | Preprint
🔗 DOI: 10.20944/preprints202501.1625.v1
👥 Contributors: Solomon Monday Jacob, Sophie Y. Akinbo, Akinola Stephen Oluwole, Temitope Agbana, Zainab Omoruyi, Michael A. Okungbowa, Diehl Jan-Carel, Fredrick O. Akinbo
Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis and Soil-Transmitted Helminths in Ekiti State, South West, Nigeria
🗓 2024-10-25 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed9110255
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.
Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis & Soil-Transmitted Helminths in Ekiti State, Nigeria
🗓 2024-09-16 | Preprint
🔗 DOI: 10.20944/preprints202409.1200.v1
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.
Instituto Politécnico de Bragança, Portugal.
Maria Helena Pimentel is a distinguished Professor Coordinator at the Polytechnic Institute of Bragança (IPB), Portugal, specializing in Nursing and Health Sciences. With decades of experience in academia and healthcare, she has contributed significantly to research in sociology, nursing education, and public health. Her leadership roles in the IPB, including serving as Director of the School of Health, demonstrate her commitment to advancing higher education and healthcare training.
Prof. Dr. Maria Helena Pimentel holds a Ph.D. in Sociology (2011) from the University of Minho, Portugal, with a thesis on "Lifestyle and Health: The Daily Life of Students at the Polytechnic Institute of Bragança." She earned a Master’s in Nursing Sciences (1999) from the University of Porto, focusing on "Nursing Students’ Perceptions of the Profession." Additionally, she completed a Postgraduate Specialization in Child and Pediatric Health Nursing (1993) at the Coimbra School of Nursing and obtained her Bachelor's Degree in Nursing (1985) from the Polytechnic Institute of Bragança, Portugal.
Prof. Dr. Maria Helena Pimentel is a Professor Coordinator (2012–present) at the Polytechnic Institute of Bragança, Portugal, where she previously served as an Adjunct Professor (2000–2012) and an Assistant Professor (1993–2000). Before her academic career, she worked as a Nurse (1986–1989) at the Bragança Hospital Unit, Portugal.
Maria Helena Pimentel's research focuses on:
Nursing Education and Training
Public Health and Healthcare Systems
Sociology of Health and Well-being
Lifestyle and Student Health
Director of the School of Health – IPB (2009–2017)
President of the Scientific and Pedagogical Council – IPB (2009–2017)
Member of the Scientific Council of IPB (2017–Present)
International Collaborations through Erasmus Programs (Spain, France, Portugal)
"Consumption of Major Psychoactive Substances During the COVID-19 Pandemic Among Higher Education Students", Revista de Enfermagem Referência (2023). DOI: 10.12707/RVI22031
"Local Health Unit: A Vertical Integration Model of Healthcare", Revista de Enfermagem Referência (2022). DOI: 10.12707/RV21061
"Human Work on the Frontline of the Pandemic: Socio-Health Assistance", Lex Social: Revista de Derechos Sociales (2021). DOI: 10.46661/lexsocial.5972
"Participation in Community Intervention Programs and Quality of Life: Findings from a Multicenter Study in Portugal", Revista Brasileira de Geriatria e Gerontologia (2020). DOI: 10.1590/1981-22562020023.190017
"Social Benefits in Portuguese Public Higher Education Over the Last Four Decades", AULA (2017). DOI: 10.14201/aula201723
Princess Margaret Cancer Centre, Canada.
Dr. James Chun Lam Chow, PhD, FCCPM, FInstP, FIET, SMIEEE, PPhys, CPhys, CSci, is a distinguished medical physicist specializing in radiation oncology and artificial intelligence applications in healthcare. He is currently an Associate Professor in Material Science and Engineering at the University of Toronto and a Clinician Investigator at the Princess Margaret Cancer Research Institute. With over two decades of experience in medical physics, his research focuses on AI-driven healthcare solutions, radiation therapy optimization, and Monte Carlo simulations for cancer treatment.
Dr. James C. L. Chow earned his PhD in Physics from the University of Hong Kong in 1995 under the supervision of Prof. Peter Fung, following a BSc in Applied Physics (First Class Honours) from City University of Hong Kong in 1992. He was awarded a Croucher Postdoctoral Fellowship at the University of Cambridge (1995-1997), then continued his research as a Postdoctoral Researcher at the University of Toronto (1997-1998) and later as a Postdoctoral Fellow at McMaster University (1998-2000). Transitioning into medical physics, he completed his Medical Physics Residency at the London Regional Cancer Centre (2000-2002), gaining clinical expertise in radiation therapy and medical imaging.
Dr. James C. L. Chow is an accomplished medical physicist and academic with extensive experience in radiation oncology and materials science. He is currently an Associate Professor in the Department of Materials Science and Engineering at the University of Toronto (2025–Present) and has been an Associate Professor in the Department of Radiation Oncology at the University of Toronto since 2019. In addition to his academic roles, he serves as a Medical Physicist at Princess Margaret Cancer Centre (2005–Present), where he also leads as the Physics On-Call Lead (2010–Present). His research contributions are further reflected in his role as a Clinician Investigator at the Princess Margaret Cancer Research Institute (2023–Present) and his affiliation with the Acceleration Consortium at the University of Toronto (2024–Present).
Previously, Dr. Chow held multiple key positions, including Assistant Professor in Radiation Oncology at the University of Toronto (2006–2019) and Medical Physics Site Lead for Skin Cancer at Princess Margaret Cancer Centre (2010–2015). Before joining Princess Margaret, he worked as a Medical Physicist and Deputy Radiation Safety Officer at Grand River Regional Cancer Centre (2002–2005). He has also contributed to academia as an Adjunct Professor at Ryerson University and the University of Waterloo (2005–2010). His career reflects a deep commitment to advancing medical physics, cancer treatment, and interdisciplinary research in materials science and engineering.
Dr. Chow’s research focuses on:
Radiation Oncology & Medical Physics: Treatment optimization using Monte Carlo simulations
Artificial Intelligence in Healthcare: AI-driven diagnostic tools and chatbot applications in oncology
Nanotechnology in Radiation Therapy: Gold nanoparticle-enhanced radiotherapy
Clinical Data Analysis: Predictive modeling for cancer treatment outcomes
2024 Outstanding Reviewer, Nuclear Engineering and Technology Journal
2024 Most-Viewed Article, JMIR Cancer
2024 Outstanding Author of the Year, AIMS Biophysics Journal
2019 Top Peer Reviewer, Web of Science Group
2012 Outstanding Reviewer, Medical Physics Journal
2010 SciNet Local Resource Allocation Award (1 million supercomputing hours for Monte Carlo simulations)
Gold nanoparticles for drug delivery and cancer therapy
S Siddique, JCL Chow
Applied Sciences 10(11), 3824 (2020) – Cited: 382
Chatbot for health care and oncology applications using artificial intelligence and machine learning: Systematic review
L Xu, L Sanders, K Li, JCL Chow
JMIR Cancer 7(4), e27850 (2021) – Cited: 375
Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow
Nanomaterials 10(9), 1700 (2020) – Cited: 325
Irradiation of gold nanoparticles by X‐rays: Monte Carlo simulation of dose enhancements and the spatial properties of secondary electron production
MKK Leung, JCL Chow, BD Chithrani, MJG Lee, B Oms, DA Jaffray
Medical Physics 38(2), 624-631 (2011) – Cited: 311
Machine learning in healthcare communication
S Siddique, JCL Chow
Encyclopedia 1(1), 220-239 (2021) – Cited: 142
American University of Beirut, Lebanon.
Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.
Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).
Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.
Oncology – Brain cancer, genetic biomarkers, metastasis
Epidemiology – Risk factors, diet effects, environmental exposure
Neurosurgery – Computational biology, single-cell DNA sequencing
Young Scientist Award – Recognized for contributions to neuroscience research
Editorial Board Member – Journal of Public Health Research
Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons
1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34
2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27
3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23
4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22
5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22
Cleveland Clinic Abu Dhabi, United Arab Emirates.
Juan S. Barajas-Gamboa is an accomplished Adjunct Clinical Professor of Surgery and Research Scholar with over 15 years of expertise in academic medicine, medical education, and strategic program development. His work spans clinical research, innovative teaching, and securing significant research funding. Passionate about fostering global research collaborations and mentoring future medical professionals, he has contributed extensively to medical education and research advancements in the Middle East and beyond.
Dr. Juan S. Barajas-Gamboa began his academic journey at Colegio La Salle in Bucaramanga, Colombia, where he earned a Bachelor of Science in Biology in November 2002. Pursuing his passion for medicine, he completed a medical internship at the Universidad Tecnológica de Pereira, Hospital Universitario San Jorge, Colombia, in July 2009. Shortly thereafter, he further enriched his clinical experience by undertaking a medical internship at the University of California, San Diego (UCSD) in June 2010. He earned his Doctor of Medicine (M.D.) degree in Medicine and Surgery from the Universidad Autónoma de Bucaramanga, Colombia, in July 2010. Following this, Dr. Barajas-Gamboa advanced his research career as a Postdoctoral Fellow in Translational and Clinical Research at UCSD, completing the program in December 2011, and continued as a Postdoctoral Fellow in Clinical Research at the same institution until July 2013.
Dr. Juan S. Barajas-Gamboa currently serves as an Adjunct Clinical Professor of Surgery at Khalifa University, UAE (2021–Present), where he focuses on developing research-driven curricula, mentoring faculty, and promoting research excellence. Since 2018, he has also been a Research Scholar at Cleveland Clinic Abu Dhabi, UAE, where he leads groundbreaking research in bariatric surgery, metabolic disorders, and personalized medicine, having successfully secured over $1.3 million in research grants. Between 2010 and 2018, Dr. Barajas-Gamboa held various research and teaching positions at institutions including UCSD and Universidad Industrial de Santander, concentrating on clinical and translational research to advance medical knowledge and practice.
Minimally invasive and robotic surgery
Bariatric and metabolic surgery
Surgical oncology
Precision medicine and patient-specific treatments
Innovations in medical education
2023: Research Scholar of the Year, Cleveland Clinic Abu Dhabi
2022: IFSO MENAC Research Scholarship, Saudi Arabia
2021: Best Abstract, Emirates Diabetes and Endocrine Congress, UAE
2009: Honorary Mention, UNAB School of Medicine
2003: Scholarship for Best Results in ICFES Examination, UNAB, Colombia
Conversion of One-Anastomosis Gastric Bypass to Roux-En-Y Gastric Bypass: Mid-Term Results from the United Arab Emirates
Authors: Alshamsi, A., Barajas-Gamboa, J.S., Piechowska-Jóźwiak, M.I., Kroh, M., Rodriguez, J.
Journal: Surgical Endoscopy, 2025, 39(1), pp. 417–424, e13314.
Focuses on outcomes of surgical conversion procedures in bariatric patients in the UAE.
Impact of the COVID-19 Lockdown on Primary Bariatric Surgery: A Comparative Study of Weight Loss Trajectories and Perioperative Outcomes
Authors: Barajas-Gamboa, J.S., Khan, M.S.I., Romero-Velez, G., Kroh, M., Rodriguez, J.H.
Journal: Journal of Laparoendoscopic and Advanced Surgical Techniques, 2024, 34(12), pp. 1107–1110.
Analyzes the effects of the pandemic on bariatric surgical outcomes and weight-loss progress.
Management of Abdominal Wall Hernias in Bariatric Patients: A Narrative Review
Authors: Restrepo-Rodas, G., Barajas-Gamboa, J.S., Fuentes, J.L.G., Vargas-Cordova, R., Guerrón, A.D.
Journal: Annals of Laparoscopic and Endoscopic Surgery, 2024, 9.
Explores surgical management strategies for abdominal wall hernias in patients undergoing bariatric surgery.
Diastasis Recti with Concomitant Ventral Hernia Repair: An Initial Experience in the United Arab Emirates Population
Authors: Guerron, A.D., Restrepo-Rodas, G., Barajas-Gamboa, J.S., Cherubino, M., Rodriguez, J.
Journal: Journal of Laparoendoscopic and Advanced Surgical Techniques, 2024, 34(10), pp. 904–909.
Reports on the outcomes of managing diastasis recti alongside hernia repair in UAE patients.
Pain Assessment and Analgesic Requirements after Sleeve Gastrectomy: A Comparison Study of Robotic versus Laparoscopic Approaches
Authors: Barajas-Gamboa, J.S., Ihsan Khan, M.S., Mocanu, V., Kroh, M., Corcelles, R.
Journal: Journal of Clinical Medicine, 2024, 13(17), 5168.
Compares pain management outcomes between robotic and laparoscopic techniques in sleeve gastrectomy.
Peking University, China.
Prof. Junyu Zhou is a pioneering researcher in nutritional genomics, metabolic disorders, and personalized medicine. He leverages bioinformatics, computational biology, and experimental approaches to explore gene-diet interactions, focusing on Asian populations. His innovative work includes developing AI models for bioactive compound prediction and uncovering gut microbiota's role in metabolic health. Junyu's recent research extends to natural compound discovery for neurodegenerative diseases, emphasizing computational screening with advanced AI techniques.
Junyu Zhou holds advanced degrees in fields related to nutritional genomics and computational biology. His academic training provides a strong foundation for his cutting-edge research in metabolic disorders and personalized medicine.
As an Assistant Researcher at Peking University, Junyu Zhou has led and collaborated on multiple groundbreaking projects. His experience spans computational modeling, experimental validations, and interdisciplinary collaborations with global research teams in metabolic diseases and nutritional genomics.
Nutritional Genomics 🧬
Junyu Zhou investigates gene-diet interactions to understand how genetic variations influence nutritional responses, particularly in Asian populations. His work aims to develop personalized dietary recommendations to improve health outcomes.
Metabolic Diseases 🩺
Focusing on conditions such as diabetes and obesity, Junyu studies the underlying mechanisms of metabolic disorders. His research integrates genetics and gut microbiota to unveil new therapeutic targets.
Computational Biology & Bioinformatics 💻
Junyu applies advanced computational tools to analyze genetic data and predict drug-target interactions. His expertise in bioinformatics helps bridge data science and biology for innovative discoveries.
Gut Microbiota 🌱
Exploring the role of gut microbiota in metabolic health, Junyu's research uncovers microbial contributions to diseases and identifies probiotic strategies for improved metabolic functions.
Natural Product Research 🌿
Junyu's work includes computational screening of natural compounds, focusing on their potential to treat diseases such as Alzheimer's and neurodegenerative disorders.
Personalized Medicine 🩹
By integrating genomics and computational biology, Junyu develops precision healthcare approaches, tailoring interventions to individual genetic and metabolic profiles.
Machine Learning in Drug Discovery 🤖
Junyu employs AI-driven techniques to streamline drug discovery processes. His work includes predictive models for bioactive compounds, enhancing efficiency in identifying new therapeutic agents.
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype, Published in: International Journal of Molecular Sciences, 2024, Contributors: Yuan, H.; Wu, X.; Wang, X.; Zhou, J.-Y.; Park, S. Link
Predicting structure-targeted food bioactive compounds for middle-aged and elderly Asians with myocardial infarction: insights from genetic variations and bioinformatics-integrated deep learning analysis, Published in: Food & Function, 2024, Contributors: Junyu Zhou; Heng Yuan; Sunmin Park. Link
Association of Metabolic Diseases and Moderate Fat Intake with Myocardial Infarction Risk, Published in: Nutrients, December 11, 2024, Contributors: Junyu Zhou; Meiling Liu; Sunmin Park. Link
UPMC, United States.
Alaa A. Sayed is a dedicated physician and researcher specializing in internal medicine and regenerative medicine. Currently serving as the Chief Resident in Internal Medicine at UPMC Mercy Hospital in Pittsburgh, Pennsylvania, Alaa's career spans significant roles across clinical practice, research, and global health initiatives. Her work at institutions like the University of Pittsburgh and the World Health Organization reflects her commitment to patient safety and medical innovation.
Alaa earned her MBBCh with honors from Beni Suef University, Egypt, demonstrating her early commitment to medical excellence. She further specialized in regenerative medicine by completing a Master’s degree in Novel Therapeutics from Imperial College London. Her research focused on pioneering cardiac stem cell therapies, reflecting her dedication to advancing innovative treatments in cardiovascular health.
Alaa brings a wealth of experience across various medical and research roles. She served as an Internal Medicine Chief Resident at UPMC Mercy Hospital, where she honed her clinical leadership skills. At the McGowan Institute for Regenerative Medicine, she contributed as a Research Fellow, deepening her expertise in regenerative therapies. Her career also includes a tenure as a Visiting Research Scholar at the University of Missouri and work as a Quality and Patient Safety Consultant with the World Health Organization. Alaa’s dedication to community health is evident in her role as a Primary Care Physician with the Egyptian Ministry of Health.
Research Specializations: Regenerative Medicine, Patient Safety, and Quality Care
Alaa’s research is deeply rooted in advancing regenerative medicine, particularly focusing on patient safety and quality care. Her work emphasizes the potential of stem cell therapies, striving to bridge the gap between innovative treatments and effective clinical practices.
Technical Expertise: Dry and Wet Lab Techniques
Alaa is highly skilled in both dry and wet lab methodologies, with extensive experience in cultivating and manipulating stem cell cultures. Her technical acumen extends to bioinformatics and AI-driven analysis, where she applies advanced algorithms to enhance diagnostic and therapeutic outcomes.
AI in Healthcare: Deep Learning and Performance Validation
Alaa’s work frequently intersects with thematic analysis and the validation of deep learning models tailored for healthcare. Her research aims to optimize performance metrics of AI applications, ensuring accurate, reliable, and patient-centered results.
Alaa has been recognized for her excellence in patient safety research, and her contributions have been honored by organizations like the WHO and UPMC.
Her awards reflect her impact on improving patient care and advancing medical research.
Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Authors: A. Elgebaly, I. A. I. Radwan, M. M. AboElnas, H. H. Ibrahim, M. F. M. Eltoomy,
Journal: Journal of Gastrointestinal & Liver Diseases, 26(1), 2017. Citations: 89. Link
Functional Microvascularization of Human Myocardium In Vitro
Authors: O. King, D. Cruz-Moreira, A. Sayed, F. Kermani, W. Kit-Anan, I. Sunyovszki,
Journal: Cell Reports Methods, 2(9), 2022. Citations: 24. Link
Implementation Research on Measuring Quality in Primary Care: Balancing National Needs with Learning from the Eastern Mediterranean Region
Authors: M. Letaief, L. R. Hirschhorn, S. Leatherman, A. A. Sayed, A. Sheikh, S. Siddiqi
Journal: International Journal for Quality in Health Care, 33(3), mzab119, 2021. Citations: 7. Link
Vascularized Myocardium-On-A-Chip: Excitation-Contraction Coupling in Perfused Cardiac Co-Cultures
Authors: O. King, D. Cruz-Moreira, S. W. Kit-Anan, A. Sayed, B. Wang, J. Fourre,
Journal: Biophysical Journal, 118(3), 410a, 2020. Citations: 2. Link
Long-Term Association of Low-Density Lipoprotein Subtypes with Coronary Artery Calcium Score and Atherosclerotic Cardiovascular Disease Events: Insights from HeartSCORE Study
Authors: A. Sayed, J. Swanson, K. Kip, E. K. Jesrani, S. Reis, A. Saeed
Journal: Journal of Clinical Lipidology. Link